Document is current
Any future updates will be listed below
-
Authors
Kim, Kyuwon
Yoon, A-Ran
Oh, Kyunghwan
Hong, Hee Seung
Lee, Jae Yong
Hong, Seung Wook
Hwang, Sung Wook
Park, Sang Hyoung
Yang, Dong-Hoon
Byeon, Jeong-Sik
Myung, Seung-Jae
Ye, Byong Duk
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea grant (2021R1A2C2095096)
- License Information
-
More Information
Article History
Received: 7 October 2025
Accepted: 4 February 2026
First Online: 16 February 2026
Declarations
:
: BDY reports consulting fees from AbbVie Korea, BMS Pharmaceutical Korea Ltd., Celltrion, Chong Kun Dang Pharm, CJ Red BIO, Curacle, Daewoong Pharm, Dong-A ST, Ferring Korea, Hanmi Pharmaceutical, Imscout, IQVIA, Johnson & Johnson, Johnson & Johnson Korea, Jeil Pharmaceutical Co., Kangstem Biotech, Korea Otsuka Pharm, Korea United Pharm, Lilly Korea, Medtronic Korea, NanoEntek, ORGANOIDSCIENCES Ltd., Pfizer Korea, Samsung Bioepis, Takeda, Takeda Korea and Yuhan; speaker fees from AbbVie Korea, BMS Pharmaceutical Korea Ltd., Celltrion, Cornerstones Health, Curacle, Daewoong Pharm, Eisai Korea, Ferring Korea, IQVIA, Johnson & Johnson Korea, Pfizer Korea, Samsung Bioepis, and Takeda Korea; and research support from Celltrion and Pfizer Korea. None of these is relevant to this article. The other authors declare no competing interest.
